Ginekol Pol
-
The pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become the reason of the global health crisis. Since the first case of diagnosed COVID-19 pneumonia was reported in Wuhan, Hubei Province, China, in December 2019, the infection has spread rapidly to all over the world. The knowledge gained from previous human coronavirus infection outbreaks suggests that pregnant women and their foetuses represent a high-risk population during infectious disease epidemics. ⋯ The constantly increasing number of publications regarding the course of COVID-19 infection in pregnant women has been published, however, the available data remains limited and many questions remain unanswered. The aim of this review was to summarize the literature data and adjusted to current recommendations regarding pregnancy care, delivery and postpartum period. An extremely important issue is the need to register all the cases of COVID-19 affected women and the course of these pregnancies to local, regional, or international registries, which will be helpful to answer many clinical and scientific questions and to create guidelines ensuring an adequate level of care for women affected by COVID-19 infection during pregnancy, delivery and during postpartum period, as well as their newborns.
-
Congenital diaphragmatic hernia (CDH) is a developmental discontinuity of the diaphragm. It allows abdominal viscera to herniate into the chest and leads to lung hypoplasia. ⋯ In selected cases, a prenatal procedure to improve neonatal survival is possible. The authors of this manuscript believe their work might contribute to a better understanding of congenital diaphragmatic hernia and patient selection for the FETO (fetal endoscopic tracheal occlusion) surgery or expectant management.
-
The aim of the study was to present and analyze the verdicts of the Supreme Medical Court concerning professional misconduct among obstetrics and gynecology specialists between 2002-2012. ⋯ A respective jurisdiction approach may be observed in the Supreme Medical Court ruling against cases concerning professional misconduct which are also criminal offences (i.e., illegal abortion, working under the influence). The most frequent types of professional misconduct should determine areas for professional training of obstetrics and gynecology specialists.
-
Review
[Decision-to-delivery interval (DDI) for emergency cesarean sections in Polish healthcare system].
Cesarean section is one of most common obstetric procedures, with the incidence of 33.9-43.1% of all labors in Poland. If the indication for cesarean section is 'immediate threat to maternal or fetal life', then the procedure must be performed without delay. The fact that time elapsed between decision to operate and delivery (decision-to-delivery interval, DDI) affects fetal outcome has been widely discussed. ⋯ Anesthesiologists deem patients eligible for anesthesia and are also responsible for efficiency of its administration. Furthermore, few additional factors which seem to be fundamentally important in achieving optimal DDI have been identified and they depend on hospital management decisions, namely sufficient number of qualified staff, regular training in emergency procedures, availability of operating theaters, as well as fast and safe transportation of patients between the admission room, obstetrics department and operating theaters. In conclusion, we wish to emphasize that optimal DDI depends on proper collaboration of numerous teams, what may be important when discussing personal responsibility in obstetric failures.
-
Worldwide screening for early detection of ovarian cancer in both, the general population and the group of women at high risk for ovarian cancer including BRCA genes mutations carriers, has proven to be ineffective. The recommended screening methods, including a pelvic examination, transvaginal ultrasound, and CA125 performed biannually continue to fail due to their relatively low sensitivity specificity and positive predictive value tests, as well as the fact that cancer is still detected in advanced stages (FIGO III/IV). However proteomic techniques and the ongoing search for more sensitive and specific biomarkers to increase effectiveness of screening tests for ovarian cancer bring new hope. We reviewed the current literature on screening for ovarian cancer in BRCA genes mutations carriers.